US FDA Warns NJ Firm On Drug And Supplement GMPs, Indian Firm On Diethylene Glycol Testing

Agency’s latest posting of warning letters submitted also includes more warnings about OTC hand sanitizer production failing to meet GMP requirements.

• Source: Shutterstock

A US firm with drug and dietary supplement manufacturing quality control problems and an Indian firm inadequately testing for diethylene glycol in an ingredient typically used in toothpaste are among the consumer health businesses recently warned by US regulators.

More from Compliance

More from Policy & Regulation